Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05532592
Other study ID # KY2022-138-B
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 27, 2022
Est. completion date May 30, 2022

Study information

Verified date September 2022
Source RenJi Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.


Description:

On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Questionnaire items including demographic characteristics, understanding of COVID-19, attitude toward COVID-19 vaccine. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.


Recruitment information / eligibility

Status Completed
Enrollment 449
Est. completion date May 30, 2022
Est. primary completion date May 10, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. age = 18 2. recipients after liver transplantation surgery Exclusion Criteria: 1. Incomplete data (missing questionnaire information), such as lack of age, gender, indication for transplantation, time after transplantation and other indicators 2. loss to follow-up 3. COVID-19 vaccination before liver transplantation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Perceptions and attitudes towards COVID-19 and COVID-19 vaccine
Attitude towards COVID-19; Knowledge about COVID-19 vaccine

Locations

Country Name City State
China The department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
RenJi Hospital

Country where clinical trial is conducted

China, 

References & Publications (9)

Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation. 2021 Jan 1;105(1):37-55. doi: 10.1097/TP.0000000000003523. Review. — View Citation

Chen T, Li X, Li Q, Huang L, Cai Q, Wang Y, Jiang Y, Xu Q, Lv Q, Wang J. COVID-19 vaccination hesitancy and associated factors among solid organ transplant recipients in China. Hum Vaccin Immunother. 2021 Dec 2;17(12):4999-5006. doi: 10.1080/21645515.2021.1984133. Epub 2021 Sep 29. — View Citation

Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021 Apr;74(4):944-951. doi: 10.1016/j.jhep.2021.01.032. Epub 2021 Feb 6. Review. — View Citation

Costantino A, Invernizzi F, Centorrino E, Vecchi M, Lampertico P, Donato MF. COVID-19 Vaccine Acceptance among Liver Transplant Recipients. Vaccines (Basel). 2021 Nov 11;9(11). pii: 1314. doi: 10.3390/vaccines9111314. — View Citation

Facciolà A, Visalli G, Orlando A, Bertuccio MP, Spataro P, Squeri R, Picerno I, Di Pietro A. Vaccine hesitancy: An overview on parents' opinions about vaccination and possible reasons of vaccine refusal. J Public Health Res. 2019 Mar 11;8(1):1436. doi: 10.4081/jphr.2019.1436. eCollection 2019 Mar 11. — View Citation

Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ; AASLD COVID-19 Vaccine Working Group. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology. 2021 Aug;74(2):1049-1064. doi: 10.1002/hep.31751. — View Citation

MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. Epub 2015 Apr 17. — View Citation

Russo FP, Piano S, Bruno R, Burra P, Puoti M, Masarone M, Montagnese S, Ponziani FR, Petta S, Aghemo A; Italian Association for the Study of the Liver. Italian association for the study of the liver position statement on SARS-CoV2 vaccination. Dig Liver Dis. 2021 Jun;53(6):677-681. doi: 10.1016/j.dld.2021.03.013. Epub 2021 Apr 30. — View Citation

Stucchi RSB, Lopes MH, Kumar D, Manuel O. Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation. 2018 Feb;102(2S Suppl 2):S72-S80. doi: 10.1097/TP.0000000000002012. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants with COVID-19 Vaccine Hesitancy In the questionnaire, participants who expressed hesitancy or explicitly refused to receive the COVID-19 vaccine were considered vaccine hesitancy. through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT05994820 - Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India N/A
Completed NCT05537441 - Precision Vaccine Promotion in Underserved Populations N/A
Recruiting NCT05998824 - COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease N/A
Terminated NCT05167422 - Trusted Messenger Intervention N/A
Completed NCT04939506 - COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana N/A
Recruiting NCT05787015 - Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy N/A
Enrolling by invitation NCT06062056 - Motivational Interviewing for Vaccine Uptake in Latinx Adults N/A
Recruiting NCT05473936 - A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination N/A
Not yet recruiting NCT05531058 - The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy N/A
Not yet recruiting NCT05120817 - Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy N/A
Completed NCT05206669 - Testing Messages to Promote HPV Vaccination N/A
Completed NCT06155877 - Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents N/A
Completed NCT06124131 - Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening N/A
Recruiting NCT06417762 - Dime La VerDAD: Verify, Debunk, and Disseminate N/A
Recruiting NCT06297876 - COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color N/A
Enrolling by invitation NCT06156228 - Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos N/A
Recruiting NCT05042011 - Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
Not yet recruiting NCT06374134 - The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States
Completed NCT01385501 - Educational Intervention to Improve Vaccine Acceptance N/A
Completed NCT05582564 - The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial N/A